|
Craneware PLC on Tuesday celebrated ‘record’ half-year results and said it ‘remains confident’ in its outlook for the current financial year. The Edinburgh, Scotland-based software solutions provider said pretax profit rose 71% to $10.1 million for the six months ended December 31, from $5.9 million the previous year. Craneware, which is focused on the US healthcare market, also reported a 78% rise in basic earnings per share, to 20.7 US cents from 11.6 cents. Revenue increased 10% on-year to $100.0 million from $91.2 million, ‘driven mainly by expansion with existing customers, and new customer wins’. Annual recurring revenue increased 3.4% to $177.3 million from $171.4 million. Craneware also noted it has used ‘our strong cash generation to invest into our expanding product portfolio, reduce debt and interest costs, and increase our dividend whilst retaining healthy total cash reserves’. That interim dividend was 3.8% higher at 13.5 pence per share, from 13.0p per share the year before. ‘We are pleased to have delivered record interim financial results, reflecting the successful execution of our growth strategy,’ commented Chief Executive Officer Keith Neilson. ‘Our trusted position at the heart of the US healthcare market is translating into double digit growth rates, as we support our customers in the transformation of their operations and finance through our software and data driven insights.’ Looking ahead, Craneware said positive trading has continued into the second half and that it ‘remains confident in its outlook’ for the year ending June 30. It said it expects to deliver results in line with current market expectations. ‘Following the US election, hospitals are now expecting a period where they can focus on their fundamentals and make investments to drive strategic growth, which we anticipate will provide a sustained demand environment for our offerings,’ Neilson added. ‘The continued expansion of our Trisus platform, increasing engagement from major players within the US healthcare market and strong financial foundations mean we are well placed to execute on our ambitious growth strategy, as we support our customers in transforming the business of healthcare.’ Craneware’s stock was trading 0.9% higher at 1,776.00 pence per share late on Tuesday at midday in London. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
